Cerus Corporation
CERS
#7246
Rank
C$0.80 B
Marketcap
C$4.00
Share price
-6.02%
Change (1 day)
108.32%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus Corporation's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.9 Million, an increase over its 2023 earnings that were of -C$41.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-39.38%
2024 -C$16.9 Million-58.95%
2023 -C$41.16 Million-20.74%
2022 -C$51.92 Million-25.7%
2021 -C$69.88 Million-11.99%
2020 -C$79.4 Million-14%
2019 -C$92.33 Million21.73%
2018 -C$75.85 Million-0.65%
2017 -C$76.34 Million-10.96%
2016 -C$85.74 Million4.24%
2015 -C$82.26 Million50.99%
2014 -C$54.48 Million-10.08%
2013 -C$60.59 Million184.13%
2012 -C$21.33 Million-7.91%
2011 -C$23.16 Million
2009 -C$32.7 Million-24.69%
2008 -C$43.42 Million-25.2%
2007 -C$58.05 Million330.54%
2006 -C$13.49 Million1.49%
2005 -C$13.29 Million-61.02%
2004 -C$34.09 Million
2002 -C$84.31 Million10.02%
2001 -C$76.63 Million34.25%
2000 -C$57.08 Million61.02%
1999 -C$35.45 Million-18.81%
1998 -C$43.67 Million93.08%
1997 -C$22.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.32 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$20.78 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.35 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.5 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA